State of Wisconsin Investment Board’s Black Diamond Therapeutics BDTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,100	Closed	-$61.1K	–	2519
2023 Q2	$61.1K	Sell	12,100 -8,400	-41%	-$17.2K	﹤0.01%	2254
2023 Q1	$38.7K	Sell	20,500 -20,700	-50%	-$47.6K	﹤0.01%	2475
2022 Q4	$74.2K	Sell	41,200 -23,300	-36%	-$42K	﹤0.01%	2376
2022 Q3	$109K	Sell	64,500 -26,100	-29%	-$80.5K	﹤0.01%	2512
2022 Q2	$223K	Sell	90,600 -19,900	-18%	-$46.3K	﹤0.01%	2438
2022 Q1	$306K	Buy	+110,500	New	+$403K	﹤0.01%	2089
2021 Q2	–	Sell	-24,400	Closed	-$592K	–	2076
2021 Q1	$592K	Sell	24,400 -1,100	-4%	-$29.7K	﹤0.01%	1538
2020 Q4	$817K	Buy	25,500 +6,900	+37%	+$227K	﹤0.01%	1382
2020 Q3	$562K	Hold	18,600	–	–	﹤0.01%	1438
2020 Q2	$784K	Hold	18,600	–	–	﹤0.01%	1293
2020 Q1	$464K	Buy	+18,600	New	+$566K	﹤0.01%	1370

Other funds holding BDTX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State of Wisconsin Investment Board's BDTX Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of Black Diamond Therapeutics (BDTX) in Q3 2023, closing a stake of 12,100 shares — an estimated $61.1K sold.

State of Wisconsin Investment Board first reported a position in BDTX in Q1 2020 and held it in 11 quarters. The position peaked at $817K in Q4 2020. 73 funds tracked by Wall St. Rank hold BDTX as of Q3 2023.

State of Wisconsin Investment Board reported no remaining Black Diamond Therapeutics position as of Q3 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 12,100 Black Diamond Therapeutics shares in Q3 2023, an estimated $61.1K.
State of Wisconsin Investment Board first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 11 quarters.
State of Wisconsin Investment Board's Black Diamond Therapeutics position peaked at $817K in Q4 2020.
73 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.